Pages that link to "Q58298619"

The following pages link to Infrequent mutation of theWT1 gene in 77 Wilms' tumors (Q58298619):

Displaying 47 items.

• Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors (Q24304875) (← links)
• WT1 proteins: functions in growth and differentiation (Q28191433) (← links)
• Frasier and Denys-Drash syndromes: different disorders or part of a spectrum? (Q33734434) (← links)
• Genetics of Beckwith-Wiedemann syndrome-associated tumors: common genetic pathways (Q33875930) (← links)
• Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? (Q33890336) (← links)
• Wilms tumor genetics (Q34067724) (← links)
• Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas (Q34346138) (← links)
• Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors (Q34408171) (← links)
• Target genes of the WNT/beta-catenin pathway in Wilms tumors (Q34507325) (← links)
• Software and database for the analysis of mutations in the human WT1 gene (Q34647004) (← links)
• WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study (Q34667826) (← links)
• Analysis of wilms tumors using SNP mapping array-based comparative genomic hybridization. (Q34841380) (← links)
• Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1. (Q35576147) (← links)
• WT1 exon 1 deletion/insertion mutations in Wilms tumor patients, associated with di- and trinucleotide repeats and deletion hotspot consensus sequences (Q35643818) (← links)
• Stratification of Wilms tumor by genetic and epigenetic analysis (Q35987087) (← links)
• Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology (Q36108223) (← links)
• Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study (Q36200428) (← links)
• Wilms' tumour: connecting tumorigenesis and organ development in the kidney (Q36234726) (← links)
• Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers (Q36431320) (← links)
• New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes (Q37127104) (← links)
• Genetic variation frequencies in Wilms' tumor: A meta-analysis and systematic review (Q37146691) (← links)
• The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity (Q37179425) (← links)
• Candidate genes and potential targets for therapeutics in Wilms’ tumour (Q37790163) (← links)
• Multicenter study identified molecular blood-born protein signatures for Wilms Tumor (Q38331911) (← links)
• Detection of a novel t(6;15)(q21;q21) in a pediatric Wilms tumor (Q38492004) (← links)
• Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype (Q39631733) (← links)
• Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis (Q40262816) (← links)
• Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters (Q40850830) (← links)
• Differential splicing of exon 5 of the Wilms tumour (WT1) gene (Q41097558) (← links)
• A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5. (Q41235668) (← links)
• The Wilms Tumour GeneWT1in Leukaemia (Q41663756) (← links)
• Molecular basis of Wilms’ tumor (Q41717547) (← links)
• The Wilms' Tumor 1 Gene: Oncogene or Tumor Suppressor Gene? (Q41729420) (← links)
• WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries? (Q44642720) (← links)
• WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact (Q45345263) (← links)
• Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters (Q46803214) (← links)
• Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development. (Q52531672) (← links)
• WT1 expression does not disrupt myogenic differentiation in C2C12 murine myoblasts or in human rhabdomyosarcoma. (Q52550912) (← links)
• Correlation of chromosome abnormalities with presence or absence of WT1 deletions/mutations in Wilms tumor. (Q53765119) (← links)
• New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors. (Q54547476) (← links)
• Genotype/phenotype correlations in Wilms' tumor (Q71580257) (← links)
• Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis (Q71795922) (← links)
• High frequency of loss of heterozygosity for 1p35-p36 (D1S247) in Wilms tumor (Q73515268) (← links)
• Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours (Q73780146) (← links)
• Chromosome analyses of 16 cases of Wilms tumor: different pattern in unfavorable histology (Q75211371) (← links)
• Mutations/deletions of the WT1 gene, loss of heterozygosity on chromosome arms 11p and 11q, chromosome ploidy and histology in Wilms' tumors in Japan (Q77357613) (← links)
• Sporadic human renal tumors display frequent allelic imbalances and novel mutations of the HRPT2 gene (Q79387201) (← links)